SCHEMBL17065809

SCHEMBL17065809

COc1ccc2c(N3CCOCC3)c(Br)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.50
ALDH1A1 P00352 5/20 0.50
HPGD P15428 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C19 P33261 1/20 0.50
PRKDC P78527 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
RAB9A P51151 1/20 0.47
TSHR P16473 3/20 0.47
HSD17B10 Q99714 3/20 0.47
CASP1 P29466 1/20 0.47
CLK1 P49759 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
MAPT P10636 5/20 0.43
MAPK1 P28482 2/20 0.43
PIK3CD O00329 2/20 0.43
PIK3CA P42336 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17065822 0.86 ACHE (0.47) KDM4EALDH1A1CYP1A2RAB9ACASP1
SCHEMBL17065812 0.75 PRKDC (0.46) KDM4EALDH1A1PRKDCGAATSHR
SCHEMBL2430853 0.74 ALDH1A1 (0.48) KDM4EALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL16104548 0.70 PRKDC (0.56) KDM4EALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL8273165 0.70 ALDH1A1 (0.63) KDM4EALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL15266968 0.70 CYP1A2 (0.48) KDM4ECYP1A2CLK1MAPTAPP
SCHEMBL5752191 0.70 CYP2A6 (0.48) KDM4ECYP1A2RAB9AMAPTKMT2A
SCHEMBL1536606 0.69 ALDH1A1 (0.62) KDM4EALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL1536583 0.69 ALDH1A1 (0.62) KDM4EALDH1A1HPGDCYP1A2CYP2C19
SCHEMBL1536692 0.69 KDM4E (0.62) KDM4EALDH1A1HPGDCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113768-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS Universita' Degli Studi Di Pavia (IT) 2017-01-11 EP disclosed
WO-2015132733-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS UNIVERSITA' DEGLI STUDI DI PAVIA (IT) 2015-09-11 WO disclosed